Literature DB >> 17314681

Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage.

Pavel Krejci1, Deborah Krakow, Pertchoui B Mekikian, William R Wilcox.   

Abstract

Fibroblast growth factors (FGF) regulate bone growth, but their expression in human cartilage is unclear. Here, we determined the expression of entire FGF family in human fetal growth plate cartilage. Using reverse transcriptase PCR, the transcripts for FGF1, 2, 5, 8-14, 16-19, and 21 were found. However, only FGF1, 2, 17, and 19 were detectable at the protein level. By immunohistochemistry, FGF17 and 19 were uniformly expressed within the growth plate. In contrast, FGF1 was found only in proliferating and hypertrophic chondrocytes whereas FGF2 localized predominantly to the resting and proliferating cartilage. In addition, only the 18 kD isoform of FGF2 was found in resting chondrocytes while proliferating chondrocytes also synthesized 22 kD and 24 kD FGF2, similar to in vitro cultivated chondrocytes. In cell growth experiments, FGF1, 2, and 17 but not FGF19 inhibited the proliferation of FGFR3-expressing rat chondrosarcoma chondrocytes (RCS) with relative potency FGF2 >> FGF1 = FGF17. We conclude that FGF1, 2, 17, and 19 are the predominant FGF ligands present in developing human cartilage that are, with the exception of FGF19, experimentally capable of inhibiting chondrocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17314681     DOI: 10.1203/pdr.0b013e318030d157

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  22 in total

Review 1.  Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias.

Authors:  Silvie Foldynova-Trantirkova; William R Wilcox; Pavel Krejci
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

Review 2.  Endocrine fibroblast growth factors 15/19 and 21: from feast to famine.

Authors:  Matthew J Potthoff; Steven A Kliewer; David J Mangelsdorf
Journal:  Genes Dev       Date:  2012-02-02       Impact factor: 11.361

3.  Instability restricts signaling of multiple fibroblast growth factors.

Authors:  Marcela Buchtova; Radka Chaloupkova; Malgorzata Zakrzewska; Iva Vesela; Petra Cela; Jana Barathova; Iva Gudernova; Renata Zajickova; Lukas Trantirek; Jorge Martin; Michal Kostas; Jacek Otlewski; Jiri Damborsky; Alois Kozubik; Antoni Wiedlocha; Pavel Krejci
Journal:  Cell Mol Life Sci       Date:  2015-02-18       Impact factor: 9.261

Review 4.  Achondroplasia: Development, pathogenesis, and therapy.

Authors:  David M Ornitz; Laurence Legeai-Mallet
Journal:  Dev Dyn       Date:  2017-03-02       Impact factor: 3.780

5.  Bioactive factors in platelet-rich plasma obtained by apheresis.

Authors:  Jan Philipp Krüger; Undine Freymannx; Samuel Vetterlein; Katja Neumann; Michaela Endres; Christian Kaps
Journal:  Transfus Med Hemother       Date:  2013-10-27       Impact factor: 3.747

6.  FGF17, a gene involved in cerebellar development, is downregulated in a patient with Dandy-Walker malformation carrying a de novo 8p deletion.

Authors:  Ginevra Zanni; Sabina Barresi; Lorena Travaglini; Laura Bernardini; Teresa Rizza; Maria Cristina Digilio; Eugenio Mercuri; Stefano Cianfarani; Massimiliano Valeriani; Alessandro Ferraris; Letizia Da Sacco; Antonio Novelli; Enza Maria Valente; Bruno Dallapiccola; Enrico Silvio Bertini
Journal:  Neurogenetics       Date:  2011-04-12       Impact factor: 2.660

Review 7.  High molecular weight FGF2: the biology of a nuclear growth factor.

Authors:  K Chlebova; V Bryja; P Dvorak; A Kozubik; W R Wilcox; P Krejci
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

8.  Ablation of low-molecular-weight FGF2 isoform accelerates murine osteoarthritis while loss of high-molecular-weight FGF2 isoforms offers protection.

Authors:  Patience M Burt; Liping Xiao; Thomas Doetschman; Marja M Hurley
Journal:  J Cell Physiol       Date:  2018-08-25       Impact factor: 6.384

Review 9.  Molecular pathology of the fibroblast growth factor family.

Authors:  Pavel Krejci; Jirina Prochazkova; Vitezslav Bryja; Alois Kozubik; William R Wilcox
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

10.  A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells.

Authors:  Livia Eiselleova; Kamil Matulka; Vitezslav Kriz; Michaela Kunova; Zuzana Schmidtova; Jakub Neradil; Boris Tichy; Dana Dvorakova; Sarka Pospisilova; Ales Hampl; Petr Dvorak
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.